Vimarsana
Biggest News Aggregation in the World

Page 3 - Pharma Medtech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Medtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Medtech Today - Breaking & Trending Today

AstraZeneca cuts EU vaccine supply target again - Vimarsana News

AstraZeneca cuts EU vaccine supply target again

Shortfall a further blow to EU’s vaccination plans already hampered by repeated delays

EU expected to approve single-shot Johnson & Johnson vaccine - Vimarsana News

EU expected to approve single-shot Johnson & Johnson vaccine

Company to deliver 200m doses to EU with 600,000 to Republic between April and June

Steve Cutler: 'People understand what a clinical trial is now' - Vimarsana News

Steve Cutler: 'People understand what a clinical trial is now'

America will continue to be the focus. While Icon’s business is currently split evenly between the US and Europe (with the rest of the world accounting for 20 per cent), around two-thirds of all mandates come from US pharma companies. That reality is reflected in the fact that Cutler, like his predecessor Ciaran Murray is largely based over there. However, the acquisition will double Icon’s resources in the important Japanese market and in China. Where Icon previously had strategic partnerships – arrangements that deliver substantial work and revenues – with 40 per cent of...

Medical experts recommend authorisation of Johnson & Johnson's one-dose Covid-19 vaccine - Vimarsana News

Medical experts recommend authorisation of Johnson & Johnson's one-dose Covid-19 vaccine

EU has deal with company for millions of doses

Johnson & Johnson's Covid-19 vaccine is safe and 72% effective – FDA - Vimarsana News

Johnson & Johnson's Covid-19 vaccine is safe and 72% effective – FDA

No Covid-related deaths reported in the group vaccinated in clinical trial